More Patients Sue Japan For Hepatitis B From Re-Used Syringes
This article was originally published in PharmAsia News
Executive Summary
Another 67 patients infected with hepatitis B have filed lawsuits against the government of Japan, seeking compensation for same-syringe shots. The suits seek a combined total of $23.2 million from the government, claiming children were infected with the disease when they were vaccinated with reused syringes. The suits assert the government knew as far back as 1948 that reusing syringes would lead to infection, but did not take precautions. (Click here for more
You may also be interested in...
Entries Begin To Roll In For 2024 Industry Awards
Entries have now begun rolling in for the Global Generics & Biosimilars Awards, which returns to Milan this October, Free to enter and attend, the ceremony recognizes the top achievements across the generics, biosimilars and value added medicines industries.
‘I Would Love To Have All The Biologic Assets’ – Formycon’s Glombitza Sets Out Portfolio Approach
In the second part of an exclusive interview, Formycon CEO Stefan Glombitza talks to Generics Bulletin about key regulatory developments in Europe and the US, the firm’s portfolio selection strategy, and upcoming milestones on the horizon.
First Off The Blocks, Fresenius Launches US Tocilizumab Biosimilar
Fresenius Kabi has kicked off competition to Genentech’s Actemra in the US, launching its Tyenne biosimilar version of tocilizumab.